Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 23:33:19 - browse：7

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Big Tobacco's 'harm reduction': Is it for real, or a sham?

knowledge

WSS

Mystery swirls around US soldier who entered North Korea days ago, officials say

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

'CMA Fest' 2023: How to watch, who is performing and more

5 dead in mass shooting on Caribbean island of St. Vincent: Police

The stock market has soared this year, but will it last? Experts weigh in

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

hotspot

Wikipedia

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Venture capitalist Bob Kocher on the state of digital health

Peter Hotez and the public health issue of online harassment

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Trump demands the U.S. pay no more for drugs than other countries … again

It's time to retire 'poor historian' from clinicians' vocabularies

Guidelines to prevent youth baseball injuries need more muscle

NVIDIA and Google execs on the future of AI and drug discovery

focus

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Case highlights the risks of experimental stem cell therapy

Bird flu: Don't repeat Covid's 'health versus the economy' framing

HIV vaccine remains elusive. Immunologists keep trying new ideas

Second House panel advances two

leisure time

focus

knowledge

leisure time